Nanomedicine & Nanopharmaceuticals

The first nanomedicines approved for use were developed from research dating back to the 1970s.Nanopharmaceuticals such as liposomes, quantum dots, dendrimers, carbon nanotubes and polymeric nanoparticles have brought considerable changes in drug delivery and the medical system. Improved therapeutic activity and reduced toxicity in the nonclinical model systems has been showed these liposomal formulations of existing drugs showed. There is a great benefit for the patients in comparison with the conventional drugs in Nanopharmaceuticals. This fact, combined with the technical challenges in commercial-scale production of nanoparticles, led to only limited investment in nanomedicines by the major pharmaceutical companies enhanced oral bioavailability, improved dose proportionality, enhanced solubility and dissolution rate, suitability for administration and reduced food effects are several advantages of these drugs.

    Related Conference of Nanomedicine & Nanopharmaceuticals

    May 15-16, 2019

    31st Annual Congress on Nanotechnology and Nanomaterials

    Prague, Czech Republic
    May 20-21, 2019

    30th World Nano Conference

    Zurich, Switzerland
    August 29-31, 2019

    31st Nano Congress for Future Advancements

    London, UK
    September 20-21, 2019

    24th Annual Meeting on Nanomaterials Science


    San Francisco, California, USA
    October 10-11, 2019

    32nd International Conference on Advanced Nanotechnology

    Dublin, Ireland
    October 14-15, 2019

    22nd World Nanotechnology Congress

    Abu Dhabi, UAE
    December 9-10, 2019

    3rd World Congress on Nano Science and NanoTechnology

    Bangkok,Thailand
    May 11-12, 2020

    26th World Congress On NanoMaterials and Nanotechnology

    Auckland, New Zealand

    Nanomedicine & Nanopharmaceuticals Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in